🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The investigators performed a randomized, double blind controlled, prospect...
Status
Completed
Location
Multiple Locations
Start Date
2013-03
Trial ID
NCT02889692
Treatments Being Tested
The aim of this study is to explore the efficacy and toxicity of icotinib c...
Status
Completed
Location
Zhejiang Cancer Hospital
Start Date
2012-01
Trial ID
NCT01514877
Treatments Being Tested
Epidermal Growth Factor Receptor tyrosine-kinase inhibitors （EGFR-TKIs）, in...
Status
Unknown
Location
Multiple Locations
Start Date
2017-04
Trial ID
NCT03123484
Treatments Being Tested
The investigators performed a randomized, double-blind controlled, prospect...
Status
Unknown
Location
Multiple Locations
Start Date
2011-11
Trial ID
NCT01745302
This study is a prospective, multicenter, real-world study to investigate t...
Status
Unknown
Location
Guangdong Provincial People's Hospital
Start Date
2020-10-07
Trial ID
NCT04575415
Treatments Being Tested
A single arm study: EGFR-TKIs Combine With Anlotinib as First-line Treatmen...
Status
Unknown
Location
Fujian cancer hospital
Start Date
2018-10
Trial ID
NCT03720873
Treatments Being Tested
This is a nationwide, multicenter and retrospective cohort study. The purpo...
Status
Unknown
Location
Affiliated Hospital of Nantong University
Start Date
2020-08-28
Trial ID
NCT04397432
The Single-arm, multicenter study evaluate the safety and efficacy of Anlot...
Status
Unknown
Location
Guangdong General Hospital
Start Date
2019-07
Trial ID
NCT04007835
Treatments Being Tested
This is a nationwide, multicenter and prospective cohort study. The purpose...
Status
Unknown
Location
Affiliated Hospital of Nantong University
Start Date
2020-11-09
Trial ID
NCT04401059
Treatments Being Tested